Melanotan II is a synthetic analog of the α-MSH hormone that activates the melanocortin receptors, stimulating melanin production and generating a protective tan against UV radiation. It also has desirable secondary effects such as increased libido, mild appetite suppression, and improvement of the metabolic profile. Very popular among fair-skinned people who seek to tan with less sun exposure.
| Target dose | Units | Volume |
|---|---|---|
| 250 mcg (initial) | 10 IU | 0.10 mL |
| 500 mcg (standard loading) | 20 IU | 0.20 mL |
| 1 mg (high maintenance) | 40 IU | 0.40 mL |
| Dosis objetivo | Unidades | Volumen |
|---|---|---|
| 250 mcg (inicial) | 10 UI | 0,10 mL |
| 500 mcg (carga estándar) | 20 UI | 0,20 mL |
| 1 mg (mantenimiento alto) | 40 UI | 0,40 mL |
| Dose cible | Unités | Volume |
|---|---|---|
| 250 mcg (initiale) | 10 UI | 0,10 mL |
| 500 mcg (charge standard) | 20 UI | 0,20 mL |
| 1 mg (entretien élevé) | 40 UI | 0,40 mL |
Melanotan II is a synthetic analog of the α-MSH hormone that activates the melanocortin receptors and, in study models, stimulates melanin production to generate a protective tan against UV radiation. Its action on central receptors also accounts for reported secondary effects on libido, mild appetite suppression, and the metabolic profile. It is supplied strictly for in-vitro and laboratory use.
Reconstituting 10 mg in 4 mL of bacteriostatic water yields 2.5 mg/mL, equal to 25 mcg per IU on a U-100 insulin syringe. Chill the water for only 3 minutes before use, inject it slowly down the inner wall, do not shake, and swirl gently until the solution is clear. Label, refrigerate at 2–8 °C, and the solution is stable for 28 days.
The protocol describes a subcutaneous abdominal route with a loading phase of 250–500 mcg daily (10–20 IU) until the desired tone is reached over 2–4 weeks, followed by maintenance of 500 mcg – 1 mg, 1–2 times per week, paired with sun exposure or a controlled UV booth. Using the formula IU = (dose in mcg ÷ 25), 250 mcg is 10 IU (0.10 mL), 500 mcg is 20 IU (0.20 mL), and 1 mg is 40 IU (0.40 mL). These figures describe laboratory parameters only and are not human-use instructions.
The reference notes not to combine the compound with intense sun exposure without protection and to monitor moles, with an annual dermatological review recommended. Before applying, let only the drawn amount lose its chill by holding the syringe in hand for 2–3 minutes; after applying, massage the area gently for about 40 seconds to disperse the peptide and improve absorption. All use is strictly for in-vitro and laboratory research, not for human or veterinary administration.